Emily Bogen faced a critical moment when her family recognized the need for intervention. Struggling with prescription drug addiction and neurological issues from Lyme disease following past alcohol challenges, the Los Angeles resident sought specialized care at a treatment center.
Upon discovering a privately owned residential facility operated by Nomina Wellness on Vancouver Island, Shawn Bogen, Emily’s mother, had high hopes for tailored treatment, one-on-one care, and top-notch service. However, the reality fell short of expectations, with promises of a luxurious experience unmet and a price tag exceeding $30,000 for three weeks of care.
The Nomina treatment facilities in Vancouver Island and Courtenay, B.C., were marred by troubling incidents, including the tragic overdose death of a 27-year-old in October 2024. These events shed light on the broader issue of for-profit, privately owned substance use treatment facilities across Canada operating with minimal government oversight, posing risks to patients’ well-being.
Critics point out the lack of regulatory framework governing these facilities, leaving patients vulnerable to substandard care. Lisa Lapointe, former B.C. chief coroner, advocates for enhanced regulations and oversight within the recovery industry to ensure patient safety and quality of care.
The absence of stringent regulations also raises concerns about accountability when mishaps occur. Instances like the fatal overdose at Nomina underscore the need for standardized practices and proper oversight in private treatment centers to prevent similar tragedies.
Despite these challenges, the push for regulatory reforms faces hurdles in various provinces. While Quebec and Alberta offer some regulations, B.C. only partially regulates registered private facilities. Ontario Health Minister Sylvia Jones defends the current oversight framework, emphasizing professional colleges’ role in regulating practitioners within these facilities.
Inadequate requirements for training and certification of addiction counselors further compound the problem, allowing unqualified individuals to operate in these settings. The lack of standardized practices and accountability mechanisms within the private treatment sector underscores the urgency for regulatory reforms to safeguard patients and ensure quality care.
The experiences of individuals like Emily Bogen and Kim Smith highlight the critical need for robust oversight and accountability measures within privately owned treatment facilities. As calls for regulatory reforms grow louder, the onus lies on provincial health ministries to address the gaps in the system and prioritize patient safety in the realm of addiction treatment.